The expression and its clinical significance of MMP-2 and MMP-9 in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 6, Issue 6, 2003, Pages 484-487

  Cao, Liming ^a   Yang, Hongzhong ^a   Hu, Chengping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Immunohistochemistry; Matrix metalloproteinase; Non small cell lung cancer

Indexed keywords

ENZYME ANTIBODY; GELATINASE A; GELATINASE B;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; PROGNOSIS;

EID: 0347363782     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Stetler-Stevenson WG, Hewitt R, Corcoran M, Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol, 1996, 7(3): 147-154.
2. Parsons SL, Watson SA, Brown PD, et al. Matrix metalloproteinases. Br J Surg, 1997, 84(2): 160-166.
3. Fromowitz FB, Viola MV, Chao S, et al. ras p21 expression in the progression of breast cancer. Hum Pathol, 1987, 18(12): 1268-1275.
4. Farias E, Ranuncolo S, Cresta C, et al. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer, 2000, 89(4): 389-394.
5. Thomas P, Khokha R, Shepherd FA, et al. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer. J Pathol, 2000, 190(2); 150-156.
6. Tokuraku M, Sato H, Murakami S, et al. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer, 1995, 64(5): 355-359.
7. Pritchard SC, Nicolson MC, Lloret C, et al. Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy. Oncol Rep, 2001, 8(2): 421-424.
8. Ylisirnio S, Hoyhtya M, Turpeenniemi-Hujanen T. Serum matrix metalloproteinases-2, -9 and tissue inhibitors of metalloproteinases-1, -2 in lung cancer-TIMP-1 as a prognostic marker. Anticancer Res, 2000, 20(2B): 1311-1316.
9. Herbst RS, Yano S, Kuniyasu H, et al. Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res, 2000, 6(3): 790-797.